Skip to main content
Contacts
Locations and phones

Call center 93 253 21 00

Monday to Sunday, from 8 am to 8:30 pm

Scheduling or change of appointment +34 93 253 21 00

Monday to Friday, from 8 am to 7 pm

Private Care - International Patients +34 93 600 97 83

Monday to Friday, from 8 am to 7 pm

SJD Barcelona Children's Hospital

Passeig Sant Joan de Déu, 2, 08950 Esplugues de Llobregat

How to arrive

Language -
Atención a una familia en la Unidad de diabetes del Hospital Sant Joan de Déu Barcelona

The Diabetes Centre of Excellence project aims to promote technological development, innovation and quality research

Initial date

01 Jan 2019

End date

31 Dec 2023

Duration

5 years

Status

Ongoing

Reference number

001-P-001226

Aid granted

3.285.389 euros

SJD Barcelona Children’s Hospital is leading this project in collaboration with Corporació Sanitària Parc Taulí. The aim is to transform the provision of care in childhood diabetes services, achieving personalised medicine to meet each patient’s needs based on both their biological characteristics (clinical data) and their biographical characteristics (social context and level of clinical adherence).

The Diabetes Centre of Excellence project aims to promote technological development, innovation and quality research through the following points:

  1. Improving health outcomes in the population with type 1 diabetes.
    • Transforming the way treatment is provided so that patients with diabetes may receive personalised medical care.
    • Optimally applying the available technology (continuous subcutaneous glucose infusers) and introducing a new monitoring platform.
  2. Changing the processes and the relationship model with our patients, to become a reference for organisational innovation.
  3. Creating a model of international reference, to become the epicentre of an international collaboration network led from a hospital in Catalonia.

In terms of the project’s results, it is hoped firstly to create a new model for the diagnosis and treatment of childhood type 1 diabetes, based on a model of precision medicine, and secondly to create a new funding model based on a transfer of risk to the technology provider, through a relationship model with this provider based on the purchase of services and patient-reported outcomes.

Funding: This project has been 50% co-funded (3,285,389 euros) by the European Union’s European Regional Development Fund within the framework of the Catalan ERDF 2014-2020 Operational Programme (PO FEDER Catalonia 2014-2020).

Total Cost of the Project: 6.570.778 euros.

Principal investigators: Marta Ramon Krauel y Roque Cardona Hernández